[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN105601485B - A kind of preparation method of voglibose intermediate - Google Patents

A kind of preparation method of voglibose intermediate Download PDF

Info

Publication number
CN105601485B
CN105601485B CN201510775975.6A CN201510775975A CN105601485B CN 105601485 B CN105601485 B CN 105601485B CN 201510775975 A CN201510775975 A CN 201510775975A CN 105601485 B CN105601485 B CN 105601485B
Authority
CN
China
Prior art keywords
compound
method described
benzyloxy
electrolyte
reducing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510775975.6A
Other languages
Chinese (zh)
Other versions
CN105601485A (en
Inventor
王飞
代毅
谢侨
邓祥林
罗礼平
黄超民
刘小伟
黄燕梅
黄万
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhien Biotechnology Co.,Ltd.
Original Assignee
Chongqing Zen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Zen Pharmaceutical Co Ltd filed Critical Chongqing Zen Pharmaceutical Co Ltd
Priority to CN201510775975.6A priority Critical patent/CN105601485B/en
Publication of CN105601485A publication Critical patent/CN105601485A/en
Application granted granted Critical
Publication of CN105601485B publication Critical patent/CN105601485B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides one kind and prepares voglibose key intermediate (2R, 3S, 4S, 5S) 5 hydroxyl 2,3, the method of 4 three (benzyloxy) 5 [(benzyloxy) methyl] cyclohexanone, including by the hydroxyl 4 of 2,2 dichloro 3,5,6 trityloxy 3 [(benzyloxy) methyl] (3S, 4S, 5S, 6R,) cyclohexanone is in the presence of metal class reducing agent and electrolyte, in polar solvent, obtained at a temperature of 25~55 DEG C through reduction dechlorination.The method of the present invention reduces poisonous and expensive reagent use, improves yield, greatly reduces the cost of raw material, environment-friendly, industrialized production preferably.

Description

A kind of preparation method of voglibose intermediate
Technical field
The invention belongs to technical field of medicine synthesis, it is related to a kind of voglibose key intermediate --- (2R, 3S, 4S, 5S) -5- hydroxyls -2,3, the preparation technology of 4- tri- (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone (compound ii), the change Compound is the important intermediate of voglibose.
Background technology
Voglibose is developed for the military field pharmacy of Japan, is alpha-glucosidase inhibitor, can improve diabetes high blood after the meal Sugar.The action intensity of voglibose is stronger than like product acarbose 190~270 times in curative effect, and to gastral Alpha-glucosidase does not influence.On the other hand, the side effect of voglibose is relatively low, is typically not in hypoglycemia, also there are no The report influenceed on Liver and kidney function, its side effect is that abdominal distension and exhaust increase, patient's better tolerance.
At present, by with the chloro-3-hydroxyls -4,5 of 2,2- bis-, 6- trityloxies -3- [(benzyloxy) methyl]-(3S, 4S, 5S, 6R)-cyclohexanone (chemical compounds I) prepares voglibose key intermediate (2R, 3S, 4S, 5S) -5- hydroxyls -2,3,4- three The method of (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone (compound ii) mainly has two kinds.By document J.Org.Chem.1992,57,3642-3658 reports.
Method one:Chemical compounds I and tri-butyl tin hydride, azodiisobutyronitrile are stirred into 1h, generationization for 100 DEG C in toluene Compound II.
Tri-butyl tin hydride and azodiisobutyronitrile are the method use, two kinds of materials are expensive, and toxicity is big, no Beneficial to environmental protection, it is unfavorable for industrialized production.
Method two:By chemical compounds I and 5% Pd-BaSO4And sodium acetate is in tetrahydrofurfuryl carbinol mixed solution, 3~ 3.5Kg/cm2Hydro-reduction under Hydrogen Vapor Pressure, room temperature reaction is stayed overnight, and generates compound ii.
This method is inflammable and explosive due to having used pressurized with hydrogen, dangerous high;It also using precious metal palladium, valency simultaneously Lattice are expensive, and toxicity is larger, is I class heavy metal;This another technique productions cycle is long, and yield is low, is unfavorable for industrialized production.
In view of prior art employs the expensive and larger reagent of toxicity and precious metal and uses poisonous, inflammable and explosive, Dangerous high hydrogen, and yield is low.Therefore, it is necessary to study the method for a more cost-effective suitable industrialized production.
The content of the invention
Object of the present invention is to provide a kind of voglibose key intermediate (2R, 3S, 4S, 5S) -5- hydroxyl -2, The method of 3,4- tri- (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone (i.e. compound II).The present inventor is in voglibose During synthetic test, it is found that this method is used in the presence of metal class reducing agent and electrolyte, in polar solvent, In 25~55 DEG C of temperature ranges, using compound I as raw material, target compound II is obtained after reduction dechlorination, reaction equation is as follows.This Outside, the yield that method of the invention obtains product is 80%~90%, and 40%~70% compared with document report is significantly improved.With Prior art is compared, and method of the invention reduces poisonous and expensive reagent use, improves yield, greatly reduces former material Expect cost, environment-friendly, industrialized production preferably.
The present invention provides one kind and prepares voglibose key intermediate (2R, 3S, 4S, 5S) -5- hydroxyls -2,3,4- three The method of (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone (i.e. compound ii), including compound I is reduced in metal class In the presence of agent and electrolyte, in polar solvent, target product chemical combination is obtained after reduction dechlorination at a temperature of 25~55 DEG C Thing II.
The method of the invention described above, further comprises target product through suction filtration, concentration, refined, obtains compound II.
The method of the invention described above, the metal class reducing agent and compound I mol ratio are 10:1~50:1.The gold Belong to class reducing agent for iron powder, zinc powder or copper powder, electrolyte and compound I mol ratio are 5:1~50:1, the electrolyte is Ammonium chloride, ammonium sulfate, ammonium carbonate, ammonium oxalate, frerrous chloride or ferrous sulfate.It is preferred that reaction temperature be 30-40 DEG C.
The method of the invention described above, the polar solvent be selected from ethanol, acetonitrile, N, dinethylformamide, hydrous ethanol, Containing water-acetonitrile and aqueous N, dinethylformamide, wherein, the hydrous ethanol, containing water-acetonitrile and aqueous N, N- dimethyl formyl In amine, the percent by volume of its water content is 0.2~15%.
The method of the invention described above, it is described refined including the use of petroleum ether, octane, heptane, or hexane, or its mixed solvent Dissolved compound II, mashing, is cooled to 0~30 DEG C, suction filtration is dried under reduced pressure.
In one embodiment, one kind of the invention prepares voglibose intermediate (2R, 3S, 4S, 5S) -5- hydroxyls Base -2,3, the method for 4- tri- (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone (compound ii), comprises the following steps:
A. in the presence of metal class reducing agent and electrolyte, in polar solvent, at 25~55 DEG C, preferred 30-40 temperature In the range of degree, using chemical compounds I as raw material, target product i.e. compound ii is obtained after reduction dechlorination;
B. reaction solution step a obtained separates out crystal after refined, is filtrated to get compound through suction filtration, evaporated under reduced pressure Ⅱ。
In the embodiment of the invention described above, described metal class reducing agent is iron powder, zinc powder, copper powder;Consumption is change Compound I 10~50 equivalents (mol ratio), described electrolyte is ammonium chloride, ammonium sulfate, ammonium carbonate, ammonium oxalate, frerrous chloride, Ferrous sulfate, preferably ammonium chloride, consumption are the equivalents of compound I 5~50 (mol ratio).
In the embodiment of the invention described above, the polar solvent is ethanol, acetonitrile, N, dinethylformamide;Contain Water-ethanol (the volume % of water content 0.2~15 volume %), containing water-acetonitrile (the volume % of water content 0.2~15 volume %), aqueous N, Dinethylformamide (the volume % of water content 0.2~15 volume %), consumption is 10~50 times of volumes of chemical compounds I.
In the embodiment of the invention described above, the process for purification is including the use of petroleum ether, octane, heptane, hexane, or Its mixed solvent dissolved compound II, mashing, is cooled to 0~30 DEG C, crystallization, suction filtration is dried under reduced pressure.
The method beneficial outcomes of the present invention are:(the benzyls of (2R, 3S, 4S, 5S) -5- hydroxyls -2,3,4- three that the present invention is provided Epoxide) -5- [(benzyloxy) methyl]-cyclohexanone (compound I) prepare method, reduce poisonous and expensive reagent use, The inflammable and explosive technique of high-pressure hydrogenation has been got rid of, yield is improved, the cost of raw material is greatly reduced, it is environment-friendly, it is preferably Industrialized production.Embodiment
Following examples are used for the essence for further understanding the present invention, the scope of but do not limit the invention in any way.
Embodiment 1 (2R, 3S, 4S, 5S) -5- hydroxyls -2,3,4- three (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone The preparation of (compound ii)
345g zinc powders, 94.6g ammonium chlorides, 510g acetonitriles and 15.3g water input 5L there-necked flasks are taken, stirring, water-bath liter is opened Temperature starts that 110g compounds I acetonitrile solution 2000ml is added dropwise, 30~35 DEG C of temperature control, drop finishes, and reaction is complete to 30~35 DEG C Afterwards, suction filtration, 40~45 DEG C of evaporated under reduced pressure, ethyl acetate 1500ml and 1000ml 2N salt acid extractions, 1000ml saturated aqueous common salts Wash, anhydrous magnesium sulfate is dried, suction filtration, evaporated under reduced pressure, add 600ml n-hexanes, flow back 0.5h, is cooled to 0~10 DEG C, suction filtration, 50 DEG C are dried under reduced pressure and obtain 86.1g white solids, purity 97.86%, yield 88%.
The compound II of acquisition is tested with HPLC, and efficient liquid phase testing conditions are shown in Table 1, as a result such as table 2 below.
The efficient liquid phase testing conditions of table 1
The efficient liquid phase testing result of table 2
Sequence number Retention time min Peak area Area percentage %
1 2.521 6639 0.054
2 2.703 25472 0.205
3 4.006 6434 0.052
4 5.426 8435 0.068
5 8.357 1243 0.010
6 9.303 8883 0.072
7 10.490 32971 0.266
8 11.336 61528 0.496
9 13.376 1156 0.009
10 18.283 35261 0.284
11 19.517 32023 0.258
12 21.192 3034 0.024
13 25.718 12143754 97.86
Embodiment 2 (2R, 3S, 4S, 5S) -5- hydroxyls -2,3,4- three (benzyloxy) -5- [(benzyloxy) methyl]-cyclohexanone The preparation of (compound ii)
297.6g iron powders are taken, 189.5g ammonium chlorides, 400ml N, dinethylformamide put into 5L there-necked flasks, open and stir Mix, warming-in-water starts that 110g compounds I acetonitrile solution 400ml is added dropwise, 35~40 DEG C of temperature control, drop finishes, instead to 35~40 DEG C After answering completely, suction filtration, evaporated under reduced pressure, ethyl acetate 1500ml and 1000ml2N salt acid extraction, the washing of 1000ml saturated common salts, nothing Water magnesium sulfate is dried, suction filtration, evaporated under reduced pressure, adds 600ml normal heptanes, and flow back 0.5h, is cooled to 0~5 DEG C, suction filtration, and 50 DEG C subtract Pressure is dried to obtain 78.3g white solids, purity 97.90%, yield 80%.
Finally illustrate, the above embodiments are merely illustrative of the technical solutions of the present invention and it is unrestricted, although pass through ginseng According to the preferred embodiments of the present invention, invention has been described, it should be appreciated by those of ordinary skill in the art that can Using in the form and details to its as it is various change, without departing from appended claims limited it is of the invention Spirit and scope.

Claims (7)

1. a kind of method for preparing voglibose intermediate compound II, including
Compound I compounds II
By compound I in the presence of metal class reducing agent and electrolyte, in polar solvent, through also at a temperature of 25~55 DEG C Target product is obtained after former dechlorination, target product is further obtained into compound II through suction filtration, concentration, refined, wherein, it is described Metal class reducing agent is iron powder, zinc powder or copper powder, and the electrolyte is ammonium chloride, ammonium sulfate, ammonium carbonate, ammonium oxalate, protochloride Iron or ferrous sulfate.
2. according to the method described in claim 1, the metal class reducing agent and compound I mol ratio are 10:1~50:1.
3. according to the method described in claim 1, wherein, electrolyte and compound I mol ratio are 5:1~50:1.
4. according to the method described in claim 1, the temperature is 30-40 DEG C.
5. according to the method described in claim 1, the polar solvent be selected from ethanol, it is acetonitrile, N, dinethylformamide, aqueous Ethanol, containing water-acetonitrile and aqueous N, dinethylformamide.
6. method according to claim 5, wherein, the hydrous ethanol, containing water-acetonitrile and aqueous N, N- dimethyl formyl In amine, the percent by volume of its water content is 0.2~15%.
7. according to the method described in claim 1, wherein, it is described refined including the use of petroleum ether, octane, heptane, or hexane, or Its blending ingredients is beaten, and is cooled to 0~30 DEG C, suction filtration is dried under reduced pressure.
CN201510775975.6A 2015-11-11 2015-11-11 A kind of preparation method of voglibose intermediate Active CN105601485B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510775975.6A CN105601485B (en) 2015-11-11 2015-11-11 A kind of preparation method of voglibose intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510775975.6A CN105601485B (en) 2015-11-11 2015-11-11 A kind of preparation method of voglibose intermediate

Publications (2)

Publication Number Publication Date
CN105601485A CN105601485A (en) 2016-05-25
CN105601485B true CN105601485B (en) 2017-11-07

Family

ID=55981914

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510775975.6A Active CN105601485B (en) 2015-11-11 2015-11-11 A kind of preparation method of voglibose intermediate

Country Status (1)

Country Link
CN (1) CN105601485B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898986A (en) * 1986-09-09 1990-02-06 Takeda Chemical Industries, Ltd. Inosose derivatives, production and use thereof
CN104098458A (en) * 2014-08-07 2014-10-15 重庆植恩药业有限公司 Preparation method of voglibose intermediate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049547A1 (en) * 2003-11-21 2005-06-02 Ranbaxy Laboratories Limited Process for the preparation of 1,2,3,4-cyclohexanetetrol derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898986A (en) * 1986-09-09 1990-02-06 Takeda Chemical Industries, Ltd. Inosose derivatives, production and use thereof
CN104098458A (en) * 2014-08-07 2014-10-15 重庆植恩药业有限公司 Preparation method of voglibose intermediate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
2,3,4,6-四-O-苄基井冈霉烯胺的合成;杨光丽等;《化学研究与应用》;20090531;第21卷(第5期);730-733 *
Synthesis of a Branched-Chain Inosose Derivative, a Versatile Synthon of N-Substituted Valiolamine Derivatives from D-Glucose;Hiroshi Fukase et al.;《J.Org.Chem.》;19921231;第57卷(第13期);3642-3650 *

Also Published As

Publication number Publication date
CN105601485A (en) 2016-05-25

Similar Documents

Publication Publication Date Title
WO2014170759A8 (en) Process of producing 1,4-butanediol
Dulcevscaia et al. New copper (II) complexes with isoconazole: Synthesis, structures and biological properties
Pellei et al. Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu (I) and Cu (II) complexes
CN105601485B (en) A kind of preparation method of voglibose intermediate
Yang et al. Progress in the synthesis of analogues of bistetrahdro-isoquinoline antitumor alkaloids
Siddiqi et al. Enhanced production of ginsenoside Rh2 (S) from PPD-type major ginsenosides using BglSk cloned from Saccharibacillus kuerlensis together with two glycosidase in series
CN105130999B (en) A kind of synthetic method of Xi Gelieting impurity
CN105315332A (en) CIPPC-AA-OBzl, and preparation, nano structure, activity and application thereof
CN102249987B (en) Combretastatin compound and preparation method and application thereof
CN105239130A (en) High-antiseptic aluminum alloy anode oxide film non-nickel sealant and preparation method thereof
CN107163166A (en) A kind of preparation method of chitosan tartaric acid rare earth complex
CN104447394A (en) Novel synthesis process of ubenimex
CN105111155B (en) A kind of synthetic method of 4,7- diaza spiro [2.5] octane -7- t-butyl formate
CN109516951B (en) Preparation method of nicorandil trimer
CN103880708A (en) Improved catalytic synthesis method of malononitrile
CN105175400B (en) A kind of preparation method of afatinib intermediate
CN104447787B (en) The method of separation and purification two kinds of sesquiterpene lactones compounds and application from artemisiifolia
CN106995467A (en) A kind of method that microwave catalysis synthesizes bicycloplatin
CN104961851B (en) Inner salt compound formed by two types of polymers, and preparation method and application of inner salt compound
CN102631918B (en) Nano ruthenium-rhodium catalyst, preparation of catalyst and application of catalyst in hydrogenation reaction process
CN106519071A (en) Synthetic method of antitumor drug 6-hydroxy seleninic acid esterification chitosan copper
CN106542973A (en) Ta Simeiqiong intermediates and preparation method thereof
CN105200489A (en) Heat-resistant aluminum alloy anode oxide film nickel-free hole sealing agent and preparation method thereof
CN101508719A (en) 11-deoxidized glycyrrhetinic acid-3-0-succinic acid half ester rare earth salt and synthetic method thereof
CN109071481A (en) Method for generating maltol Fe composition by elemental iron

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 401328 No.1-6 standard workshop, Jinfeng biomedical industrial park, 28 Gaoxin Avenue, Jiulongpo District, Chongqing

Patentee after: Zhien Biotechnology Co.,Ltd.

Address before: 400039 Jiulongpo District of Chongqing Science Park Road No. 73 of 25 layers

Patentee before: Chongqing Zen Pharmaceutical Co.,Ltd.

CP03 Change of name, title or address